Haemonetics Corp 最大收入来源是 Plasma Products and Services,在最近的收益报告中收入为 563,734,000。就地区而言, United States 是 Haemonetics Corp 的主要市场,收入为 1,010,918,000。
Ark7 Properties Plus LLC 是否盈利?
是的,根据最新的财务报表,Haemonetics Corp 的净利润为 $167
Ark7 Properties Plus LLC 有负债吗?
是的,Haemonetics Corp 的负债为 1,630
Ark7 Properties Plus LLC 的流通股有多少?
Haemonetics Corp 的总流通股为 48.21
关键数据
前收盘价
$31.8
开盘价
$31
当日区间
$31.8 - $31.8
52周范围
$31 - $31.8
交易量
32
平均成交量
239
股息收益率
--
每股收益(TTM)
--
市值
--
什么是 AKPPS?
Ark7 Properties Plus LLC is engaged in the business of establishing series for holding of properties to be acquired. The company is headquartered in San Francisco, California. The company went IPO on 2023-01-26. Ark7 Properties’ investment strategy is centered around the acquisition, management, and strategic operation of residential properties situated in vibrant and growing cities across the United States. Each property that Ark7 Properties acquires is held within a distinct series of its Delaware series limited liability company structure, created specifically to acquire and manage that residential property. Ark7 Properties is a wholly owned subsidiary of Ark7 Inc. (Ark7). Ark7 operates a digital platform for real estate investment, making it simpler for investors to engage in property ownership. Ark7 acquires residential properties, converts these into fractional interests, and offers these shares through its platform.